Adipose tissue-skeletal muscle crosstalk: Are endocannabinoids an unwanted caller?

Diabetologia

Volumn 52, Issue 4, 2009, Pages 571-573

  Watt, M J ^a  

^a MONASH UNIVERSITY   (Australia)

Author keywords

Adipose tissue; Endocannabinoids; Insulin resistance; Skeletal muscle

Indexed keywords

ANANDAMIDE; CANNABINOID RECEPTOR; ENDOCANNABINOID; GLYCOGEN SYNTHASE KINASE 3ALPHA; GLYCOGEN SYNTHASE KINASE 3BETA; PHOSPHOLIPID; RIMONABANT;

ADIPOCYTE; ADIPOSE TISSUE; CELL MEMBRANE; FOOD INTAKE; GLUCOSE INTOLERANCE; GLUCOSE TRANSPORT; INSULIN RESISTANCE; INSULIN SENSITIVITY; LIPOGENESIS; NOTE; OBESITY; PHENOTYPE; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; SIGNAL TRANSDUCTION; SKELETAL MUSCLE; WEIGHT GAIN;

ADIPOSE TISSUE; DIABETES MELLITUS; ENDOCANNABINOIDS; GLUCOSE INTOLERANCE; HUMANS; INSULIN RESISTANCE; MUSCLE, SKELETAL; OBESITY; RECEPTOR CROSS-TALK; RECEPTORS, CANNABINOID;

EID: 61449146932     PISSN: 0012186X     EISSN: 14320428     Source Type: Journal    
DOI: 10.1007/s00125-009-1287-x     Document Type: Note

References (16)

1. HE Bays JM Gonzalez-Campoy GA Bray 2008 Pathogenic potential of adipose tissue and metabolic consequences of adipocyte hypertrophy and increased visceral adiposity Expert Rev Cardiovasc Ther 6 343 368
2. DB Savage KF Petersen GI Shulman 2007 Disordered lipid metabolism and the pathogenesis of insulin resistance Physiol Rev 87 507 520
3. RH Unger 2003 Minireview: weapons of lean body mass destruction: the role of ectopic lipids in the metabolic syndrome Endocrinology 144 5159 5165
4. SP Weisberg D McCann M Desai M Rosenbaum RL Leibel AW Ferrante Jr 2003 Obesity is associated with macrophage accumulation in adipose tissue J Clin Invest 112 1796 1808
5. Eckardt K, Sell H, Taube A et al (2009) Cannabinoid type 1 receptors in human skeletal muscle cells participate in the negative crosstalk between fat and muscle. Diabetologia. doi: 10.1007/s00125-008-1240-4
6. D Cota 2007 CB1 receptors: emerging evidence for central and peripheral mechanisms that regulate energy balance, metabolism, and cardiovascular health Diabetes Metab Res Rev 23 507 517
7. M Bluher S Engeli N Kloting 2006 Dysregulation of the peripheral and adipose tissue endocannabinoid system in human abdominal obesity Diabetes 55 3053 3060
8. D Cota G Marsicano M Tschop 2003 The endogenous cannabinoid system affects energy balance via central orexigenic drive and peripheral lipogenesis J Clin Invest 112 423 431
9. R Motaghedi TE McGraw 2008 The CB1 endocannabinoid system modulates adipocyte insulin sensitivity Obesity (Silver Spring) 16 1727 1734
10. L Bellocchio C Cervino V Vicennati R Pasquali U Pagotto 2008 Cannabinoid type 1 receptor: another arrow in the adipocytes' bow J Neuroendocrinol 20 Suppl 1 130 138
11. B Kola E Hubina SA Tucci 2005 Cannabinoids and ghrelin have both central and peripheral metabolic and cardiac effects via AMP-activated protein kinase J Biol Chem 280 25196 25201
12. T Watanabe N Kubota M Ohsugi 2009 Rimonabant ameliorates insulin resistance via both adiponectin-dependent and adiponectin-independent pathways J Biol Chem 284 1803 1812
13. V Di Marzo 2008 The endocannabinoid system in obesity and type 2 diabetes Diabetologia 51 1356 1367
14. R Christensen PK Kristensen EM Bartels H Bliddal A Astrup 2007 Efficacy and safety of the weight-loss drug rimonabant: a meta-analysis of randomised trials Lancet 370 1706 1713
15. L Van Gaal X Pi-Sunyer JP Despres C McCarthy A Scheen 2008 Efficacy and safety of rimonabant for improvement of multiple cardiometabolic risk factors in overweight/obese patients: pooled 1-year data from the Rimonabant in Obesity (RIO) program Diabetes Care 31 Suppl 2 S229 S240
16. I Miljkovic-Gacic CL Gordon BH Goodpaster 2008 Adipose tissue infiltration in skeletal muscle: age patterns and association with diabetes among men of African ancestry Am J Clin Nutr 87 1590 1595